These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 17122646

  • 1. The clinical significance of circulating tumor cells in the peripheral blood.
    Elshimali YI, Grody WW.
    Diagn Mol Pathol; 2006 Dec; 15(4):187-94. PubMed ID: 17122646
    [Abstract] [Full Text] [Related]

  • 2. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.
    Smirnov DA, Foulk BW, Doyle GV, Connelly MC, Terstappen LW, O'Hara SM.
    Cancer Res; 2006 Mar 15; 66(6):2918-22. PubMed ID: 16540638
    [Abstract] [Full Text] [Related]

  • 3. HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.
    Fabjani G, Tong D, Wolf A, Roka S, Leodolter S, Hoecker P, Fischer MB, Jakesz R, Zeillinger R.
    Oncol Rep; 2005 Sep 15; 14(3):737-41. PubMed ID: 16077985
    [Abstract] [Full Text] [Related]

  • 4. Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
    Alunni-Fabbroni M, Sandri MT.
    Methods; 2010 Apr 15; 50(4):289-97. PubMed ID: 20116432
    [Abstract] [Full Text] [Related]

  • 5. Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis.
    Bluemke K, Bilkenroth U, Meye A, Fuessel S, Lautenschlaeger C, Goebel S, Melchior A, Heynemann H, Fornara P, Taubert H.
    Cancer Epidemiol Biomarkers Prev; 2009 Aug 15; 18(8):2190-4. PubMed ID: 19661076
    [Abstract] [Full Text] [Related]

  • 6. Clinical value of circulating endothelial cell detection in oncology.
    Kraan J, Sleijfer S, Foekens JA, Gratama JW.
    Drug Discov Today; 2012 Jul 15; 17(13-14):710-7. PubMed ID: 22306349
    [Abstract] [Full Text] [Related]

  • 7. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM, Lou B, Ye SR, Cao M, He X, Li P, Hu K, Rao L, Wu SM, Xiao HB, Gao E.
    Ann Surg Oncol; 2008 Nov 15; 15(11):3073-82. PubMed ID: 18670822
    [Abstract] [Full Text] [Related]

  • 8. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
    Danova M, Torchio M, Mazzini G.
    Expert Rev Mol Diagn; 2011 Jun 15; 11(5):473-85. PubMed ID: 21707456
    [Abstract] [Full Text] [Related]

  • 9. [Circulating tumor cells: isolation, quantification, and relevance of their translation into clinical practice].
    Olivier Gómez C, Carballido Rodríguez J.
    Actas Urol Esp; 2010 Jan 15; 34(1):3-5. PubMed ID: 20223125
    [No Abstract] [Full Text] [Related]

  • 10. [Detection and clinic implication of circulating tumor cell in patients with lung cancer].
    Mu XL, Li LY.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun 15; 26(3):313-8. PubMed ID: 15266838
    [Abstract] [Full Text] [Related]

  • 11. Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer.
    Friel AM, Corcoran C, Crown J, O'Driscoll L.
    Breast Cancer Res Treat; 2010 Oct 15; 123(3):613-25. PubMed ID: 20549336
    [Abstract] [Full Text] [Related]

  • 12. [Biologic detection methods in the comparison of circulating tumor cells and micrometastases].
    Dombóvári Z, Molnár B, Bocsi J, Láng I, Papik K, Fehér J, Tulassay Z.
    Orv Hetil; 1998 Jul 26; 139(30):1793-7. PubMed ID: 9718947
    [Abstract] [Full Text] [Related]

  • 13. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-analysis.
    Katsuno H, Zacharakis E, Aziz O, Rao C, Deeba S, Paraskeva P, Ziprin P, Athanasiou T, Darzi A.
    Ann Surg Oncol; 2008 Nov 26; 15(11):3083-91. PubMed ID: 18787906
    [Abstract] [Full Text] [Related]

  • 14. Circulating tumor cells and aberrant methylation as tumor markers in patients with esophageal cancer.
    Ikoma D, Ichikawa D, Ueda Y, Tani N, Tomita H, Sai S, Kikuchi S, Fujiwara H, Otsuji E, Yamagishi H.
    Anticancer Res; 2007 Nov 26; 27(1B):535-9. PubMed ID: 17348438
    [Abstract] [Full Text] [Related]

  • 15. Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells.
    Silva HC, Garcao F, Coutinho EC, De Oliveira CF, Regateiro FJ.
    Neoplasma; 2006 Nov 26; 53(6):538-43. PubMed ID: 17167725
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of circulating tumour cells expressing CD44 variants in the blood of gastric cancer patients by flow cytometry.
    Pituch-Noworolska A, Wieckiewicz J, Krzeszowiak A, Stachura J, Ruggiero I, Gawlicka M, Szczepanik A, Karcz D, Popiela T, Zembala M.
    Anticancer Res; 1998 Nov 26; 18(5B):3747-52. PubMed ID: 9854488
    [Abstract] [Full Text] [Related]

  • 19. Detection, clinical relevance and specific biological properties of disseminating tumour cells.
    Pantel K, Brakenhoff RH, Brandt B.
    Nat Rev Cancer; 2008 May 26; 8(5):329-40. PubMed ID: 18404148
    [Abstract] [Full Text] [Related]

  • 20. Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
    Apostolaki S, Perraki M, Kallergi G, Kafousi M, Papadopoulos S, Kotsakis A, Pallis A, Xenidis N, Kalmanti L, Kalbakis K, Agelaki S, Kalykaki A, Stournaras C, Stathopoulos E, Georgoulias V, Mavroudis D.
    Breast Cancer Res Treat; 2009 Oct 26; 117(3):525-34. PubMed ID: 19016323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.